KOLOA, Hawaii — Distinguishing between benign and malignant lesions is key when managing eyelid lesions, a speaker said at Hawaiian Eye 2023.
“I do not send every lesion for pathology ... but if things look a little abnormal, I think it is reasonable to send,” Andrew Harrison, MD, said.
If the clinical suspicion of malignancy and the pathology results do not agree, he considers repeating the biopsy.
Features that may prompt suspicion that a lesion is malignant are growth over time, in that malignancies often grow more rapidly than lesions (Read more...)